Molecular imaging with 18F-flubatine PET/MRI has shown that neuroreceptors in the brains of individuals with obesity respond differently to food cues than those in normal-weight individuals, making the neuroreceptors a prime target for obesity treatments and therapy. This research contributes to the understanding of the fundamental mechanisms underlying obesity and offers valuable insights into potential medical interventions.